Allogeneic cultured keratinocytes and fibroblasts - Organogenesis

Drug Profile

Allogeneic cultured keratinocytes and fibroblasts - Organogenesis

Alternative Names: Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen; Gintuit

Latest Information Update: 06 Sep 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organogenesis
  • Class Cell therapies
  • Mechanism of Action Tissue replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Gingival disorders
  • Discontinued Alveolar bone loss

Most Recent Events

  • 10 Dec 2013 Organogenesis completes enrolment in its phase I/II trial for Gingival disorders & Alveolar bone loss following tooth extraction in the USA (NCT01929954)
  • 31 Jul 2013 Phase-I/II clinical trials in Alveolar bone loss in USA (Topical)
  • 08 Apr 2013 Launched for Gingival disorders to a controlled market in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top